Jun 14, 2021 05:51 PM (GMT+8) · EqualOcean
Jingfeng pharmaceutical announced that Hainan Jinrui Pharmaceutical Co., Ltd., a subsidiary of the company, received the approval notice of drug supplement application for gemcitabine hydrochloride for injection approved and issued by the State Food and drug administration, and gemcitabine hydrochloride for injection passed the quality and efficacy consistency evaluation of generic drugs.

This text is a result of machine translation.